Aurobindo Pharma Limited has submitted a regulatory disclosure regarding its participation in an investor meeting. The company officials will participate in the 16th Annual Trinity India 2026 Global Investor Conference arranged by 360 ONE Capital.
The meeting is scheduled for May 29, 2026, from 9:00 AM to 6:00 PM IST. It will be conducted through in-person and group meetings format at Mumbai location.
The company explicitly states that no unpublished price sensitive information (UPSI) is intended to be discussed during these interactions. The disclosure notes that the meeting schedule is subject to change due to exigencies on the part of either the investor or the company.
The letter was digitally signed by B. Adi Reddy, Company Secretary, on May 25, 2026, at 17:37:30 IST. The communication was addressed to both the National Stock Exchange of India Limited and BSE Limited for their records.